COST-EFFECTIVENESS ANALYSIS OF DIFFERENT THERAPEUTIC REGIMENS IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHINA

Author(s)

Sun L, Dong H, Sun J, Wang Y, Shi W, Zhao X, Wu J
Shenyang Pharmaceutical University, Shenyang, China

OBJECTIVES To evaluate the cost-effectiveness of commonly used antimicrobial regimens in treatment of Community-acquired Pneumonia (CAP) in China. METHODS This was a retrospective study of CAP patients who received different antibiotic drugs during their hospitalization in a 1st Class, Grade A hospital in Shenyang, Liaoning between January 2011 and June 2012. Cost-effectiveness analysis was performed for the common therapeutic regimens based on both clinical practice and the main recommended antibacterial treatment of CAP from the perspective of society as a whole. For the sensitivity analysis, we used a relative measurement method and an absolute measurement method to test the strength of the study’s conclusions over a range of assumptions. RESULTS

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PIN63

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Infectious Disease (non-vaccine), Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×